The Scientific Advisory Panel (SAP) was created in 2019 to support the work of the Expert Advisory Group (EAG). The panel, composed of a pool of subject-matter experts, who provides the EAG and the Executive Director with critical insights and guidance.
The SAP has two main functions
- Upon the review of a proposed licence agreement, the MPP Executive Director will select at least three members from the SAP who have expertise in the particular disease or technological area relevant to the proposed licence. The disease-specific experts will have the opportunity to confidentially review drafts of the proposed licence and to offer comments to the EAG.
- The members of the SAP will, at the request of the MPP Executive Director, provide analysis and guidance on specific disease or medical technologies, on MPP’s annual prioritisation exercise, and/or on any other technical expertise that may be helpful to the MPP.
Members of the SAP (A to Z)
Helle Aagaard – ReAct – Action on Antibiotic Resistance
Labeeb Abboud – International AIDS Vaccine Initiative
Isabelle Andrieux-Meyer – Drugs for Neglected Diseases Initiatives (DNDi)
Naby Balde – International Diabetes Federation
David Beran – Hôpitaux Universitaires de Genève
Mark Blockman – Stellenbosch University
Grania Brigden – International Union Against Tuberculosis and Lung Disease
Jennifer Cohn – Resolve to Save Lives
Stephen Colagiuri – International Diabetes Federation
Prabhakaran Dorairaj – Director Centre for Control of Chronic Conditions, PHFI
Philippa Easterbrook – World Health Organization
James Elliot – Trustee t+ International
Nathan Ford – World Health Organization
Gavin Giovannoni – Blizard Institute of Cell and Molecular Medicine
Rajeev Gupta – Eternal Hospital Jaipur
Juzar Hooker – Aga Khan University Hospital
André Ilbawi – World Health Organization
Kees de Joncheere – Pharmaceutical Policy Consultant
Sylvia Kehlenbrink – Brigham and Women’s Hospital
N. Kumarasamy – Chennai Antiviral Research and Treatment (CART) Clinical Research Site
Karine Lacombe – Saint-Antoine Hospital (AP-HP)
Joanna Laurson-Doube – Multiple Sclerosis International Federation
Gilberto Lopes – Sylvester Comprehensive Cancer Center
Nicola Magrini – Italian Drug Agency
Yehoda Martei – UPENN Oncology Perelman School of Medicine
Salome Meyer – Cancer Alliance
Francesco Negro – Hôpitaux Universitaires de Genève
Iheanyi Okpala – University of Nigeria
Nelson Juma Otwoma – National Empowerment Network of People Living with HIV/AIDS (NEPHAK)
Anthony Oyekunle – University of Botswana
Pablo Perel – London School of Hygiene and Tropical Medicine
Roberto Reis – Center for Technological Development in Health at Oswaldo Cruz Foundation
Gojka Roglic – World Health Organization
Gracia Violeta Ross Quiroga – Bolivian Network of Positive People
Paul Ruff – University of Witwatersrand Faculty of Health Sciences
Joshi Shashank – International Diabetes Federation
Lawrence Shulman – UPENN Abramson Cancer Centre
Ursula Theuretzbacher – Center for Anti-Infective Agents
Wim Vandevelde – GNP+
Stefano Vella – Catholic University, Rome
François Venter – University of the Witwatersrand
Matteo Zignol – World Health Organization